FINWIRES · TerminalLIVE
FINWIRES

Alembic Pharmaceuticals Gets US FDA's Establishment Inspection Report for Karakhadi, India Unit

By

Alembic Pharmaceuticals (NSE:APLLTD, BOM:533573) has received an establishment inspection report from the US Food and Drug Administration (US FDA) for its injectable facility (F-III) at Karakhadi in Gujarat, India, according to a Thursday filing to the Indian stock exchanges.

The USFDA has inspected the facility between Feb. 9 and Feb. 18.

The company's shares were up nearly 2% in recent trade.

Related Articles